Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.

Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The complexity of software architecture and diverse user interactions presents challenges to ...

Biomarker testing is an integral part of personalized genome medicine medicine. Number of actionable biomarkers for solid tumours is rapidly expanding. Targeted NGS is a new gold standard, replacing ...

Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...

SEngine Precision Medicine, the precision oncology innovator matching patients to medicines based on their own tumor samples, announces the publication of a new case report showing a patient’s ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...